http://www.cnr.it/ontology/cnr/individuo/prodotto/ID289748
Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase ? and ?/?-hydrolase domain 6 (Articolo in rivista)
- Type
- Label
- Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase ? and ?/?-hydrolase domain 6 (Articolo in rivista) (literal)
- Anno
- 2014-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1021/jm500681z (literal)
- Alternative label
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Janssen F.J.; Deng H.; Baggelaar M.P.; Allara M.; Van Der Wel T.; Den Dulk H.; Ligresti A.; Van Esbroeck A.C.M.; McGuire R.; Di Marzo V.; Overkleeft H.S.; Van Der Stelt M. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
- http://www.scopus.com/inward/record.url?eid=2-s2.0-84906091270&partnerID=q2rCbXpz (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Department of Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, Netherlands; Endocannabinoid Research Group, Consiglio Nazionale delle Ricerche 80078 Pozzuoli, Napoli, Italy; Bioaxis Research, 5351 SL Berghem, Netherlands (literal)
- Titolo
- Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase ? and ?/?-hydrolase domain 6 (literal)
- Abstract
- sn-1-Diacylglycerol lipase ? (DAGL-?) is the main enzyme responsible for the production of the endocannabinoid 2-arachidonoylglycerol in the central nervous system. Glycine sulfonamides have recently been identified by a high throughput screening campaign as a novel class of inhibitors for this enzyme. Here, we report on the first structure-activity relationship study of glycine sulfonamide inhibitors and their brain membrane proteome-wide selectivity on serine hydrolases with activity-based protein profiling (ABPP). We found that (i) DAGL-? tolerates a variety of biaryl substituents, (ii) the sulfonamide is required for inducing a specific orientation of the 2,2-dimethylchroman substituent, and (iii) a carboxylic acid is essential for its activity. ABPP revealed that the sulfonamide glycine inhibitors have at least three off-targets, including ?/?-hydrolase domain 6 (ABHD6). Finally, we identified LEI-106 as a potent, dual DAGL-?/ABHD6 inhibitor, which makes this compound a potential lead for the discovery of new molecular therapies for diet-induced obesity and metabolic syndrome. © 2014 American Chemical Society. (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi